INTRODUCTION
Klinefelter syndrome (KS) (47,XXY) affects approximately 1 in 600 males. 1 The extra X chromosome, inherited with equal probability from either parent, arises from nondisjunction of parental chromosomes during gametogenesis. [1] [2] [3] Genes on the extra X chromosome are inactivated through mechanisms including methylation potentially regulated by X-inactive specific transcript (XIST); 4, 5 however, genes escaping inactivation may contribute to the KS phenotype and increase the risk of germ cell tumors (GCTs). 3, 6 GCTs are histologically heterogeneous, more common among children aged 15 to 19 years, and more common among males. [7] [8] [9] GCT incidence rates in the United States for males aged birth to 14 years are 3.5 per 1,000,000 persons and increase to 12.0 per 1,000,000 persons among adolescents. 7 Although the majority of male GCTs arise in the testes, extragonadal tumors are common and are hypothesized to arise from abnormal primordial germ cell migration during embryogenesis. 6, 10, 11 Testicular GCTs in adolescents usually are seminomas or mixed seminoma/nonseminoma, whereas testicular tumors in children aged <5 years are primarily yolk sac tumors and teratomas. 6, 12 In contrast, individuals with KS are more likely to develop mediastinal teratomas or GCTs with mixed histology. 2, 13 Mediastinal GCTs often have inferior outcomes compared with other extragonadal tumors, especially among adolescents and adults, for whom the overall survival rate is approximately 50%. 6 To our knowledge, the prevalence of KS among GCT cases is unknown. In a large case series of pediatric GCTs from the Children's Oncology Group Childhood Cancer Research Network (COG CCRN) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) , we estimated
Cancer October 1, 2018 the prevalence of KS among GCT cases and assessed differences between KS-GCT and non-KS-GCT cases by patient, tumor, and birth characteristics. We used publicly available data to estimate GCT risk in males with KS and summarized case reports of KS-GCTs
MATERIALS AND METHODS

Study Participants
The study population of children and adolescents with GCTs aged birth to 19 years from the COG CCRN has been described previously. 10 The current analysis included all male cases (433 cases) enrolled in the case-parent triad study from July 2008 to December 2015. Cases provided saliva samples using at-home collection kits that were returned to the study center, and had one parent willing to participate in the study.
All study procedures were approved by the Institutional Review Board of the University of Minnesota. Parents provided written informed consent for themselves and their children aged <18 years. GCT probands aged ≥18 years provided informed consent for study participation. Assent was obtained from children aged 8 to 17 years.
Questionnaire Data
Parents of GCT cases were asked to complete a mailed questionnaire detailing health history, demographics, and environmental exposures. Parents reported chromosomal abnormalities among the cases (yes/no: KS, Swyer syndrome, trisomy/partial trisomy of autosomes, trisomy 5, trisomy 13, Down syndrome, and unspecified). We collected birth length (<18 inches, 18-22 inches, and ≥22 inches) and weight (<5 pounds, 5-9 pounds, and ≥9 pounds), maternal and paternal age at the time of the case's birth (<25 years, 25-35 years, and ≥35 years), and cryptorchidism (yes/no).
Pathology Reports
Data were abstracted from pathology reports for study participants for tumor characteristics, including histology (germinoma, teratoma, any yolk sac tumor [pure yolk sac tumor or teratoma and yolk sac tumor histology], mixed/ other [choriocarcinoma and embryonal carcinoma], or unknown/missing) and tumor location (intracranial, extragonadal [yes/no: mediastinal], and gonadal).
DNA Extraction
Saliva samples were stored at room temperature until DNA extraction using the Autopure LS system (Qiagen, Venlo, the Netherlands) and quantification in triplicate using real-time polymerase chain reaction (ABI 7900 Prism; Applied Biosystems, Thermo Fisher Scientific, Waltham, Massachusetts) (1:10 dilution). DNA was aliquoted and stored at -20 o C until genotyped.
Genotyping and Quality Control
Genotyping was performed by the University of Minnesota Genomics Center using Illumina HumanCoreExome-12 
Determination of Sex Chromosomal Aneuploidy
Samples with a different number of sex chromosomes were determined using Genvisis (https://www.genvisis.org), which plots the median log R ratio for markers uniquely mapping to the X chromosome (x-axis) and the median log R ratio for markers uniquely mapping to the Y chromosome (y-axis) (Fig. 1 ). Unique mapping was determined by querying the probe sequence to the hg19 genome using Basic Local Alignment Search Tool (BLAST). 14 Cases with KS had median intensities matching those of females for the X chromosome and matching those of males for the Y chromosome. Participants with KS who were discovered using genotyping array but who did not have a parent report of KS on their study questionnaires were not made aware of their KS status because the study did not obtain consent from the participants to return individual level results.
Parent-of-Origin Determination
Genvisis was used to determine the parent of origin for the extra X chromosome. A series of plots of B allele frequency are shown in Figure 2 with X chromosome marker position (x-axis) and B allele percentage (y-axis), which are near 0.0, 0.5, or 1.0 for a diploid individual (0, 1, or 2 B allele copies) and near 0.0 and 1.0 for a haploid individual (0 or 1 B allele copy). Determination of the parent of origin for a subset of informative markers was performed because the parents were genotyped. If the mother was homozygous for a given marker and the child was heterozygous for that marker, then the other allele was likely paternal (red dot). Numerous red dots indicate that one X chromosome was maternal and the other was paternal in origin. No red dots indicate that both X A second method was used to determine the percentage of alleles estimated to be identical by descent (IBD) between the case and the mother (see Supporting  Fig. S1 ). The PLINK 15 (v1.90b3) "-genome" command was used to generate pairwise PI_HAT (proportion of markers IBD) estimates using X chromosome singlenucleotide polymorphisms (excluding pseudoautosomal regions and markers not uniquely mapped using BLAST) 14 with a call rate >98% and Hardy-Weinberg equilibrium P >.00001. For each sample with a partial run of homozygosity, a separate analysis that excluded markers within those regions was run. PLINK normally does not analyze markers on the X chromosome because males are haploid, and therefore the markers were recoded to be on chromosome 1 and the analysis was restricted to high-quality samples (call rate >98%) with 2 X chromosomes (female GCT cases, KS cases, and their mothers; 413 mother-child pairs). A PI_HAT value near 1.0 indicates the presence of uniparental heterodisomy (meiosis II error), in which every X chromosome genotype is identical between mother and son. Conversely a PI_HAT value near 0.5 indicates that one-half of the alleles match the mother and the extra X chromosome must be paternal in origin or a duplicated maternal chromosome (uniparental isodisomy).
Runs of Homozygosity
Runs of homozygosity are apparent by examining plots of B allele frequencies ( Fig. 2) and were defined as a region of ≥1 megabase with ≤1 heterozygous call (presumed genotyping error) per 1000 markers. X chromosomes in which all markers were homozygous indicated uniparental isodisomy (meiosis I error or postzygotic chromosomal duplication). Runs of homozygosity that spanned approximately one-half of the X chromosome length indicated partial uniparental isodisomy and partial uniparental heterodisomy (meiosis II error).
Estimation of GCT Risk in KS Cases
To determine the 1-year risk of GCT among males with KS, we obtained the number of male GCT cases (aged birth-19 years) from the Centers for Disease Control and a Number of times the mother was homozygous for a marker and the case was heterozygous for that marker, indicating paternal inheritance. b Examples of ROH can be seen in Figure 2 . If any region is homozygous, then it is from the mother. Cancer October 1, 2018
Prevention's 2013 WONDER database (593 cases) 16 and the number of males aged birth to 19 years in the United States (for 2013) (41,869,000 males) 17 and estimated the prevalence of KS among males aged birth to 19 years (2013) (1/600 1 males; 69,782 males). We determined the number of expected GCTs among males with KS based on the KS-GCT prevalence estimated in our study and calculated the absolute GCT risk, risk ratio (95% confidence interval [95% CI]), and rate (per 100,000 population) (95% CI) among males with and without KS. We assumed that KS does not impact mortality among pediatric cases. 3 Musselman et al 18 demonstrated an underrepresentation of GCTs in the CCRN, particularly among patients aged 15 to 19 years, among whom a diagnosis of KS-GCT is more common. Therefore, we estimated that 2% to 5% of GCT cases also have KS.
Statistical Analyses
Fisher's exact tests (Mann-Whitney U test for continuous age [GraphPad Prism v7.02; GraphPad Software, La Jolla, California]) were used to identify significant differences with regard to case, tumor, and birth characteristics between non-KS-GCT cases and KS-GCT cases. Five cases were excluded based on parent-reported Down syndrome (3 of which were confirmed by genotyping), trisomy/partial trisomy of autosomes (1 case), and an unspecified chromosomal abnormality (1 case). Two-sided P values were estimated for tests of statistical significance with an alpha of .05. Analyses were performed using SAS statistical software (version 9.4; SAS Institute Inc, Cary, North Carolina) (exceptions noted).
RESULTS
Genotype data were available for 433 male cases of GCT, and 13 cases (3.0%) had KS. Two KS-GCT cases had uniparental isodisomy of the entire X chromosome and 3 had partial uniparental isodisomy (Table 1) . According to genotype array data, 7 of 13 cases (54%) had an extra X chromosome of maternal origin and 6 of 13 cases (46%) received an additional paternal X chromosome. Of the 433 cases with genotyping data, 341 had survey data. Of the 9 KS cases with survey and genotyping data, 5 (56%) had KS by parent report.
Comparisons were made for case and tumor characteristics between non-KS-GCT cases and KS-GCT genotype-detected cases. The average age at the time of diagnosis for KS-GCT cases (13 cases) was 13.8 years (standard deviation, 4.4 years) compared with 12.5 years (standard deviation, 6.2 years) for non-KS-GCT cases (P=.82). There were no significant racial/ethnic or age differences observed between KS-GCT and non- KS-GCT cases (Table 2) . Mixed/other histology was most common among KS-GCT cases (46.2%) and non-KS-GCT cases (41.2%) (P=.60). Among KS-GCT cases, the majority of tumors were extragonadal (11 of 13 cases; 84.6%). Nine of the 11 extragonadal tumors were mediastinal (81.8%), which was significantly higher than the rate of extragonadal (16.8%) or extragonadal, mediastinal tumors (31.8%) noted among non-KS-GCT cases (P<.01). Of the 29 cases with a mediastinal tumor, 9 (31.0%) had KS. There were no statistically significant differences with regard to birth characteristics observed between non-KS-GCT cases (341 cases) and KS-GCT cases (9 cases) with survey data available (see Supporting  Table S1 ). We estimated the absolute risk of developing a GCT among males with KS by applying the 3% prevalence of KS in GCT cases in the current study to the estimated US population of pediatric males (aged birth-19 years; 2013). The Centers for Disease Control and Prevention's WONDER Cancer Statistics Database reported 593 GCTs among males aged birth to 19 years (2013) ( Table 3 ). The 1-year absolute risk of a pediatric male with KS developing a GCT ranged from 0.00017 to 0.00042 or approximately 1 per 6000 males to 1 per 2400 males with KS each year. Relative risks for GCTs among males with KS compared with non-KS males ranged from 12.4 (95% CI, 7.0-21.9) to 31.9 (95% CI, 31.9-46.1). Summarizing the case reports of KS-GCTs in the literature of males aged birth to 19 years, approximately 70% of KS-GCT cases had mediastinal tumors (Table 4 ) (see Supporting Table S2 ) and teratomas were the most common (50.0%).
DISCUSSION
In the current large series of male pediatric GCT cases from the COG CCRN, we observed that 3% of cases (13 of 433 cases) also had KS based on genotyping array data. The extra X chromosome originated from either parent with nearly equal probability. Of the 9 cases with parentreported survey data, 56% (5 cases) had a parent report a diagnosis of KS. KS-GCT cases were significantly more likely to have extragonadal, mediastinal tumors compared with non-KS-GCT cases and nearly one-third of mediastinal tumors were diagnosed among males with KS. As expected, the majority of GCT cases with KS were adolescents at the time of diagnosis; however, we noted that one patient with KS with a GCT was an infant with a retroperitoneal teratoma. One-year risk estimates indicated that KS cases have a large, increased risk of developing a GCT compared with males without KS.
Numerous published case reports have described males with KS who were diagnosed with GCTs. We observed similarities between the case reports and the KS-GCT cases in the current study. Among KS males aged 14 to 19 years in the literature, tumors were nearly exclusively mediastinal, 2,13,19-44 which we also observed. Tumors in the current study predominantly were of mixed histologic subtype, whereas teratomas were more commonly reported among the case reports, which could be due to the small sample size of KS-GCTs in the current study or unpublished case reports of KS-GCTs.
In the current study population, we observed that 3% of male GCT cases also had KS, whereas 0.2% of males in the general population are reported to have KS. 2, 3 To our knowledge, the exact carcinogenic mechanism of GCT initiation in males with KS is unknown; however, previous genetic analyses of pediatric and adolescent GCTs have found a significant percentage of patients had KS and other sex chromosome disorders, 45, 46 thereby suggesting a potential role of the X chromosome. The increased risk of GCT among males with KS may be due to genes escaping X inactivation on the additional chromosome because approximately 15% of genes on the normal X chromosome escape inactivation. 5 Testicular tumors in patients with an additional X chromosome had increased expression of A-Raf Proto-Oncogene, Serine/Threonine Kinase (ARAF1) and ELK1, ETS Transcription factor (ELK1), even though XIST was expressed, which is believed to Cancer October 1, 2018 regulate X inactivation. 4 Similarly, the X-linked androgen receptor was found to differ in association between seminomas and nonseminomas, suggesting that androgen receptor may contribute to GCTs in males with KS, who frequently have nonseminomas. 47 Much work remains to be done to identify the biologic mechanisms of GCT initiation among KS cases.
In the current study, only 56% of KS-GCT cases had a parent report a KS diagnosis. This is consistent with KS diagnoses occurring later in life, generally when males are trying to conceive, because infertility is a common side effect of KS. 48 However, if 44% of males with KS-GCT are unaware they have KS, this presents a clinical opportunity to increase KS testing among pediatric males with GCT. Nearly one-third of mediastinal GCT cases in the current study had KS, suggesting that KS testing may be warranted among males diagnosed with a mediastinal GCT. KS individuals are at an increased risk of GCTs, other malignancies, 49 and additional comorbidities; therefore, the early diagnosis of KS may aid in their clinical management. 3 With regard to birth characteristics, only increased birthweight appears to be a potential risk factor for GCT. 7, 50 In the current study, we observed that KS-GCT cases did not differ significantly from the non-KS-GCT cases with respect to birthweight. Viuff et al did not find a difference in birthweight between KS cases and non-KS cases, suggesting that KS does not impact birthweight. 51 We found the extra X chromosome was inherited from the mother or father with nearly equal probability, as previously reported. 2, 52, 53 Past studies have determined the parent of origin using polymerase chain reaction and restriction fragment length polymorphism assays on specific genes. We unambiguously determined the origin of the X chromosome using thousands of high-quality genotyping array markers, resulting in a striking separation between the cluster of samples with maternal versus paternal inheritance of the additional X.
As others have reported, we observed a higher, although nonsignificant, percentage of KS-GCT males born to mothers of older age. 51, [54] [55] [56] [57] There are 2 reports 55, 57 of an increased risk of KS for each decade increase in paternal age (controlling for maternal age); however, we did not observe a difference in paternal age between case groups. The role of advanced paternal age in the development of KS was unclear, but the prevailing hypothesis suggests an increasing rate of meiotic errors with increasing age; however, analyses of sperm from men of various ages and from mouse models have demonstrated mixed associations between increasing paternal age and aneuploid gametes. [58] [59] [60] Cryptorchidism is one of the few established risk factors for GCTs. 61 In the current study, the prevalence of cryptorchidism did not appear to differ between KS-GCT and non-KS-GCT cases. To our knowledge, there are 2 reports of cryptorchidism among KS-GCT cases 62, 63 and 27% to 37% of KS males have cryptorchidism. 3 As such, cryptorchidism may result from KS, thereby increasing the risk of GCTs among patients with KS, but further evidence is needed.
Although we present herein the results for a relatively large number of KS cases from a study of GCTs with array genotyping and survey data, the current study has limitations. In a study among adult males with KS by Hasle et al, the authors found a significantly increased risk of mediastinal GCTs, 64 similar to what we observed by studying the reverse relationship, namely the prevalence of KS among boys aged birth to 19 years diagnosed with a GCT. The current study sample contained 4 KS-GCT cases with genotyping data who lacked survey data. Males with KS with and without survey data did not appear to differ by age at diagnosis, race/ethnicity, or tumor histology or location (all P >.10). The results of the current study may be subject to selection bias due to the low participation rate among eligible GCT cases based on CCRN data (56%). Similarly, eligible GCT cases may not have been offered an opportunity to enroll in the current study; a lower percentage of adolescent GCT cases are captured in the CCRN 18 because these patients often attend adult treatment centers. 6 Last, although an increased risk of mediastinal GCTs has been reported among adult males with KS, 64 the data from the current study were limited to the pediatric and adolescent population and should not be extrapolated to patients aged >19 years.
The higher prevalence of KS-GCT cases noted among boys aged birth to 19 years in the current study compared with the general population (3% vs 0.2%, respectively) in conjunction with the evidence from the KS-GCT case reports among children suggests a link between KS and the development of GCTs. KS screening in the clinical setting may be warranted among pediatric and adolescent males with GCTs, particularly mediastinal GCTs, in light of the largely increased risk of GCT among males with KS.
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